(Q40179319)

18 September 2017

Investigating new standards for prophylaxis in reduction of exacerbations--the INSPIRE study methodology (English)

1 reference

18 September 2017

Terence Seemungal

1

1 reference

18 September 2017

Robert Stockley

2

1 reference

18 September 2017

Peter Calverley

3

1 reference

18 September 2017

Gerry Hagan

4

1 reference

18 September 2017

Jadwiga A Wedzicha

5

1 reference

18 September 2017

language of work or name

English

0 references

publication date

1 September 2007

1 reference

COPD: Journal of Chronic Obstructive Pulmonary Disease

18 September 2017

1 reference

18 September 2017

4

1 reference

18 September 2017

177-183

1 reference

18 September 2017

3

1 reference

COPD, a multicomponent disease: implications for management

18 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

The TORCH (towards a revolution in COPD health) survival study protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

The Canadian Optimal Therapy of COPD Trial: design, organization and patient recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

The costs of exacerbations in chronic obstructive pulmonary disease (COPD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

Toward a consensus definition for COPD exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

COPD exacerbations: the importance of a standard definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

Time course of recovery of health status following an infective exacerbation of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

Economic analysis of the Confronting COPD survey: an overview of results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

Relationship between respiratory symptoms and medical treatment in exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

Airway and systemic inflammation and decline in lung function in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

Raised CRP levels mark metabolic and functional impairment in advanced COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

Eradication therapy for early Pseudomonas aeruginosa infection in CF: many questions still unanswered.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

Addition of salmeterol to existing treatment in patients with COPD: a 12 month study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

Systemic effects of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701407862

10.1080/15412550701407862

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference